Aurobindo Pharma has decided to sell, transfer or otherwise dispose off its Unit-X, located at SIPCOT Industrial Complex, Village Kudikadu, Cuddalore in Tamil Nadu. The company is manufacturing some of the intermediates at the said unit.
The Unit was set up way back in the year 2002 and has not upgraded or expanded in the capacity as there are constraints for expansion within the same location. Further it is become unviable to manufacture those few intermediates as against directly procuring from others, now the operations have come to stand still.
The net block value of this unit as on March 31, 2012 was Rs 7.00 crore and it represents only 0.43% of total net block of fixed assets of the company.
Aurobindo Pharma’s net profit for the fourth quarter ended March 31, 2012 fell 33.70% to Rs 87.91 crore as compared to Rs 132.59 crore for the quarter ended March 31, 2011. However, the total income has increased by 3.51% to Rs 1100.41 crore for the quarter under review from Rs 1063.10 crore for the corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |